Kite swoops in to buy Carl June-founded Tmunity, gaining key to Penn's CAR-T research apparatus

Gilead Sciences-owned cell therapy leader Kite Pharma is widening its roster through acquisition, acquiring Carl June-founded Tmunity and its suite of autologous CAR-T therapies born out of the University of Pennsylvania labs.